Rethinking Personalized Medicine: AI's Limits in Clinical Trials - Neuroscience News
neurosciencenews.comSubmitted by neurosciencenewscom7688 in health
A new study reveals limitations in the current use of mathematical models for personalized medicine, particularly in schizophrenia treatment.